Impact of visual impairment on use of caregiving by individuals with age-related macular degeneration

被引:53
作者
Schmier, Jordana K.
Halpern, Michael T.
Covert, David
Delgado, Judith
Sharma, Sanjay
机构
[1] Exponent Inc, Alexandria, VA USA
[2] Alcon Res Ltd, Ft Worth, TX USA
[3] Macular Degenerat Partnership, Los Angeles, CA USA
[4] Queens Univ, Hop Hotel Dieu, Kingston, ON K7L 3N6, Canada
来源
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES | 2006年 / 26卷 / 09期
关键词
caregiving; costs and cost analysis; macular degeneration; low vision;
D O I
10.1097/01.iae.0000254890.48272.5a
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background: To assess the patient-reported use of caregiving among individuals with age-related macular degeneration (AMD) and evaluate the impact of visual impairment level on this use. Methods: A survey including the AMD Health and Impact Questionnaire and the Daily Living Tasks Dependent on Vision Questionnaire (DLTV) was mailed to members of the Macular Degeneration Partnership. The study was approved by an institutional review board, and respondents provided consent before participating. Responses were analyzed by estimated visual acuity determined by scores from the DLTV. Deidentified data were analyzed using SAS Version 8.2 (SAS Institute, Cary, NC). Results: Of 803 respondents, 56% were male, and the mean age was 73 years. Use of paid and unpaid help significantly increased as visual acuity decreased. Using a national average for caregiver time, annual costs for caregiving ranged from $225 to $47,086 depending on visual acuity. Conclusion: There are substantial differences in caregiver support with increased AMD severity. Delaying progression of AMD could result in considerable cost savings.
引用
收藏
页码:1056 / 1062
页数:7
相关论文
共 27 条
[1]   Switching patients with glaucoma or ocular hypertension from dual therapy to monotherapy: Evaluation of brimonidine as a model [J].
Abelson, MB ;
Netland, PA ;
Chapin, MJ .
ADVANCES IN THERAPY, 2001, 18 (06) :282-297
[2]  
Anand R, 2000, OPHTHALMOLOGY, V107, P2224
[3]   Methods for a population-based study of the prevalence of and risk factors for age-related maculopathy and macular degeneration in elderly European populations: the EUREYE study [J].
Augood, C ;
Fletcher, A ;
Bentham, G ;
Chakravarthy, U ;
de Jong, PVTM ;
Rahu, M ;
Seland, J ;
Soubrane, G ;
Tomazzoli, L ;
Topouzis, F ;
Vioque, J ;
Young, I .
OPHTHALMIC EPIDEMIOLOGY, 2004, 11 (02) :117-129
[4]   The burden of age-related macular degeneration - Results of a cohort study in two french referral centres [J].
Bonastre, J ;
Le Pen, C ;
Soubrane, G ;
Quentel, G .
PHARMACOECONOMICS, 2003, 21 (03) :181-190
[5]  
Bressler NM, 2003, ARCH OPHTHALMOL-CHIC, V121, P1621
[6]   A cost-utility analysis of interventions for severe proliferative vitreoretinopathy [J].
Brown, GC ;
Brown, MM ;
Sharma, S ;
Busbee, B ;
Landy, J .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2002, 133 (03) :365-372
[7]   Incremental cost-effectiveness of initial cataract surgery [J].
Busbee, BG ;
Brown, MM ;
Brown, GC ;
Sharma, S .
OPHTHALMOLOGY, 2002, 109 (03) :606-612
[8]   Measurement of indirect costs for people with vision impairment [J].
Chou, SL ;
Misajon, R ;
Gallo, J ;
Keeffe, JE .
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2003, 31 (04) :336-340
[9]   Sun exposure and age-related macular degeneration - An Australian case-control study [J].
Darzins, P ;
Mitchell, P ;
Heller, RF .
OPHTHALMOLOGY, 1997, 104 (05) :770-776
[10]   Service utilization by wife caregivers of frail older veterans [J].
Dorfman, LT ;
Holmes, CA ;
Berlin, KL .
SOCIAL WORK IN HEALTH CARE, 1997, 26 (02) :33-52